CLINICAL_TRIALS
trial_result
· 2020-07-15
Clinical Trial Update: Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children. [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 study assessing the safety and tolerability of intravenous lacosamide in children with epilepsy has completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-07-15